Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0TT5K
|
||||
Former ID |
DIB016726
|
||||
Drug Name |
MDL-27531
|
||||
Synonyms |
4-Methyl-5-(methylsulfonyl)-3-phenyl-1,2,4-triazole
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Epilepsy [ICD10:G40] | Phase 1 | [526961] | ||
Structure |
Download2D MOL |
||||
Formula |
C10H11N3O2S
|
||||
Canonical SMILES |
CN1C(=NN=C1S(=O)(=O)C)C2=CC=CC=C2
|
||||
InChI |
1S/C10H11N3O2S/c1-13-9(8-6-4-3-5-7-8)11-12-10(13)16(2,14)15/h3-7H,1-2H3
|
||||
InChIKey |
DPGDRICHXKQXEN-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 116850-44-3
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Glycine receptor | Target Info | Modulator | [526961] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Reactome | Ligand-gated ion channel transport | ||||
WikiPathways | Iron uptake and transport | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.